Market Value1,547,520,000
Total Holdings45
File Date2016-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ELOS / Syneron Medical Ltd.
UAM / Universal American Corp.
CYBX / Cyberonics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
LIVN / LivaNova PLC
MDCO / Medicines Company
NVTA / Invitae Corporation
US40425J1016 / HMS Holdings Corp.
TOYOF / Toyota Motor Corporation
KND / Kindred Healthcare, Inc.
PODD / Insulet Corporation
BIOS / BioPlus Acquisition Corp - Class A
MJN / Mead Johnson Nutrition Co.
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund Put
DRRX / DURECT Corporation
87611RAA6 / Targacept Inc Bond
UNIS / Unilife Corp
INNOCOLL AG / (47580Q103)
DXTR / Dextera Surgical Inc.
CBIO / Crescent Biopharma, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
EPRSQ / Epirus Biopharmaceuticals Inc
VCYT / Veracyte, Inc.
OFIX / Orthofix Medical Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF
US3723091043 / GenMark Diagnostics, Inc
CCRN / Cross Country Healthcare, Inc.
GHDX / Genomic Health, Inc.
REGN / Regeneron Pharmaceuticals, Inc. Put
US00C4U1L353 / Mylan N.V.
MASI / Masimo Corporation
LH / Labcorp Holdings Inc.
JCS / Pineapple Holdings Inc
ANGO / AngioDynamics, Inc.
BMY / Bristol-Myers Squibb Company Put
ARNA / Arena Pharmaceuticals Inc
ABT / Abbott Laboratories
ATXS / Astria Therapeutics, Inc.
ARIA / ARIAD Pharmaceuticals, Inc.
DGX / Quest Diagnostics Incorporated
ESRX / Express Scripts Holding Co.
NKTR / Nektar Therapeutics
HCA / HCA Healthcare, Inc.
SQNM / Sequenom, Inc.
BIOL / BIOLASE, Inc. Call
BIOL / BIOLASE, Inc.
PLX / Protalix BioTherapeutics, Inc.
NUVA / Nuvasive Inc
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
OSUR / OraSure Technologies, Inc.
BKD / Brookdale Senior Living Inc.
PTCT / PTC Therapeutics, Inc.
SPY / SPDR S&P 500 ETF Put
SEM / Select Medical Holdings Corporation